Patología dual en trastornos de ansiedadrecomendaciones en el tratamiento farmacológico

Referencias bibliográficas

• Aggarwal, A., Jain, M., Garg, A., y Jiloham R. C. (2009). Carbamazepine for serotonin reuptake inhibitor nonresponder case of obsessive compulsive disorder. Indian Journal of Medical Sciences, 63, 468-469. doi: 10.4103/0019-5359.57644
• Alamo, C., López-Muñoz, F., y Cuenca, E. (2002) Bases neurobiológicas del trastorno dual: hipótesis etiopatogénicas. En: G. Rubio, F. López-Muñoz C. Alamo, J. Santo-Domingo (Eds.), Trastornos psiquiátricos y abuso de sustancias (pp.107-131). Madrid: Editorial Médica Panamericana.
• Alderman, C. P., McCarthy, L. C., Condon, J. T., Marwood, A. C., y Fuller, J. R. (2009). Topiramate in combat-related posttraumatic stress disorder. The Annals of Pharmacotherapy, 43, 635-641.
• Alonso, J., Angermeyer, M. C., Bernertm S., Bruffaerts, R., Brugha, T. S., Bryson, H.,… ESEMeD/MHEDEA 2000 Investigators, European Study of the Epidemiology of Mental Disorders (ESEMeD) Project. (2004). 12-Month comorbidity patterns and associated factors in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatrica Scandinavica, 420, 28-37.
• Arias Horcajada, F. (2009). Prevalencia. En: J. Bobes García, y M. Casas Brugué (Coord.), Manejo clínico del paciente con patología dual (pp. 25-40). Barcelona: Socidrogalcohol.
• Arias, F., Szerman, N., Vega, P., Mesias, B., Basurte, I., Morant, C.,... Babin, F. (2013a). Alcohol abuse or dependence and other psychiatric disorders. Madrid study on the prevalence of dual pathology. Mental Health and Substance Use, 6, 339-350. DOI:10.1080/17523281.2012.748674
• Arias, F., Szerman, N., Vega, P., Mesias, B., Basurte, I., Morant, C.,... Babin,F. (2013b). Abuso o dependencia al cannabis y otros trastornos psiquiátricos. Estudio Madrid sobre prevalencia de patología dual. Actas Españolas de Psiquiatría, 41, 123-130.
• Arias, F., Szerman, N., Vega, P., Mesias, B., Basurte, I., Morant, C.,... Babín, F. (2013c). Estudio Madrid sobre prevalencia y características de los pacientes con patología dual en tratamiento en las redes de salud mental y de atención al drogodependiente. Adicciones, 25, 118-127.
• Armeli, S., Conner, T. S., Covault, J., Tennen, y H., Kranzler, H. R. (2008). A serotonin transporter gene polymorphism (5-HTTLPR), drinking-to-cope motivation, and negative life events among college students. Journal of Studies on Alcohol and Drugs, 69, 814-823.
• Back, S. E., y Brady, K. T. (2008). Anxiety disorders with comorbid substance use disorders: diagnostic and treatment considerations. Psychiatric Annals, 38, 724-729
• Baker, A. L., Thornton, L. K., Hiles, S., Hiles, y L., Lubman, D. I. (2012) Psychological interventions for alcohol misuse among people with co-occurring depression or anxiety disorders: a systematic review. Journal of Affective Disorders, 137, 217-229 doi: 10.1016/j.jad.2011.08.004
• Baltieri, D. A., Daró, F. R., Ribeiro, P. L., y de Andrade, A. G. (2008). Comparing topiramate with naltrexone in the treatment of alcohol dependence. Addiction, 103, 2035-2044.
• Bandelow, B. (1995). Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale. International Clinical Psychopharmacology, 10, 73-81.
• Bartels, M., Van den Berg, M., Sluyter, F., Boomsma, D. I., y de Geus, E.J. (2003) Heritability of cortisol levels: review and simultaneous analysis of twin studies. Psychoneuroendocrinology, 28, 121-137.
• Beck, A. T., Schuyler, D., y Herman, I. (1974). Development of suicidal intent scales. En: A. T. Beck, H. L. P. Resnick, D. J. Lettieri (Eds.), The prediction of suicide. (pp 45-46). Bowie: Charles Press.
• Berger, S. P., Winhusen, T. M., Somoza, E. C., Harrer, J. M., Mezinskis, J. P., Leiderman, D. B.,… Elkashef, A. (2005). A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence. Addiction, 100, 58-67.
• Berlin, H. A., Koran, L. M., Jenike, M. A., Shapira, N. A., Chaplin W., Pallanti, S., y Hollander, E. (2011). Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder. Journal of Clinical Psychiatry, 72, 716-721
• Bisaga, A., Aharonovich, E., Garawi, F., Levin, F. R., Rubin, E., Raby, W. N., y Nunes, E. V. (2006). A randomized placebo-controlled trial of gabapentin for cocaine dependence. Drug and Alcohol Dependence, 81, 267-274.
• Blake, D. D., Weathers, F. W., Nagy, L. M., Kaloupek, D. G., Klauminzer, G., Charney, D. S., y Krane, T. M. (1990). A clinician rating scale for assessing current and lifetime PTSD: the CAPS-1. Behavior Therapist, 13, 187-188.
• Bobes, J., Badía, X., Luque, A., García, M., González, M. P., y Dal-Ré, R. (1999) Validation of the Spanish version of the Liebowitz social anxiety scale, social anxiety and distress scale and Sheehan disability inventory for the evaluation of social phobia. Medicina Clinica (Barcelona), 112, 530-538.
• Bobes, J., Calcedo-Barba, A., García, M., François, M., Rico-Villademoros, F., González, M. P,… Grupo Español de Trabajo para el Estudio del Trastorno por Estrés Postraumático. (2000). Evaluation of the psychometric properties of the Spanish version of 5 questionnaires for the evaluation of post-traumatic stress syndrome. Actas Españolas de Psiquiatria, 28, 207-218.
• Bobes, J., Carreño, J. E., Gutiérrez, C. E., San Narciso, G. I., Antuña, M. J., Díaz, T.,… García-García, M. (2004). Study of effectiveness of craving control with topiramate in patients with substance dependence disorders. Actas Españolas de Psiquiatria, 32, 299-306.
• Bobes. J., García-Calvo, C., Prieto, R., García-García, M., y Rico-Villademoros, F., Grupo Español de Trabajo para la validación de la versión española de la Escala de Detección del Trastorno de Ansiedad Generalizada según DSM-IV (Escala de TAG de Carroll y Davidson). (2006). Psychometric properties of the Spanish version of the screening scale for DSM-IV Generalized Anxiety Disorder of Carroll and Davidson. Actas Españolas de Psiquiatria, 34, 83-93.
• Bonnet, U., Banger, M., Leweke, F. M., Specka, M., Müller, B. W., Hashemi, T.,... Gastpar, M. (2003). Treatment of acute alcohol withdrawal with gabapentin: results from a controlled two-center trial. Journal of Clinical Psychopharmacology, 23, 514-519.
• Bonn-Miller, M. O., Bernstein, A., Sachs-Ericsson, N., Schmidt, N. B., y Zvolensky, M. J. (2007). Associations between psychedelic use, abuse, and dependence and lifetime panic attack history in a representative sample. Journal of Anxiety Disorders, 21, 730-741.
• Bradwejn, J., Ahokas, A., y Stein, D. J. (2005). Venlafaxine extended-realease capsules in panic disorder: flexible-dose, double-blind, placebo-controlled study. British Journal of Psychiatry, 187, 352-359.
• Brady, K. T., y Verduin, M. L. (2005). Pharmacotherapy of comorbid mood, anxiety, and substance use disorders. Substance Use & Misuse, 40, 2021-2041
• Brady, K. T., Sonnem S., Antonm R. F., Randallm C. L., Back, S. E., y Simpson, K. (2005). Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcoholism: Clinical and Experimental Research, 29, 395–401.
• Brower, K. J., Myra Kim, H., Strobbe, S., Karam-Hage, M. A., Consens, y F., Zucker, R. A. (2008). A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia. Alcoholism: Clinical and Experimental Research, 32, 1429-1438.
• Brown, E. S., Nejtek, V. A., Perantie, D. C., Orsulak, P. J., y Bobadilla, L. (2003) Lamotrigine in patients with bipolar disorder and cocaine dependence. Journal of Clinical Psychiatry, 64, 197-201.
• Brown, E. S., Perantie, D. C., Dhanani, N., Beard, L., Orsulak, P., y Rush, A.J. (2006) Lamotrigine for bipolar disorder and comorbid cocaine dependence: a replication and extension study. Journal of Affective Disorders, 93, 219-222.
• Buckley, P. F., y Brown, E. S. (2006). Prevalence and consequences of dual diagnosis. Journal of Clinical Psychiatry, 67, e01.
• Buckner, J. D., Schmidt, N. B., Lang, A. R., Small, J. W., Schlauch, R. C., y Lewinsohn, P. M. (2008) Specificity of social anxiety disorder as a risk factor for alcohol and cannabis dependence. Journal of Psychiatry Research, 42, 230-239.
• Buckner, J. D., y Schmidt, N. B. (2009). Social anxiety disorder and marijuana use problems: the mediating role of marijuana effect expectancies. Depression Anxiety, 26, 864-870.
• Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H.,… Poulton, R. (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTTLPR gene. Science, 301, 386-389.
• Chambless, D. L., Cherney, J., y Caputo, G. C. (1987) Anxiety disorders and alcoholism: a study with inpatient alcoholics. Journal of Anxiety Disorders, 18, 29-40.
• Chong, R. Y., Oswald, L., Yang, X., Uhart, M., Lin, P. I., y Wand, G. S. (2006) The mu-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress. Neuropsychopharmacology, 31, 204-211.
• Cleck, J. N., y Blendy, J. A. (2008) Making a bad thing worse: adverse effects of stress on drug addiction. The Journal of Clinical Investigation, 118, 454-461.
• Conway, K. P., Compton, W., Stinson, F. S., y Grant, B. F. (2006). Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry, 67, 247-257.
• Cosci, F., Schruers, K. R., Abrams, K., y Griez, E. J. (2007). Alcohol use disorders and panic disorder: a review of the evidence of a direct relationship. Journal of Clinical Psychiatry, 68, 874-880.
• Covault, J., Tennen, H., Armeli, S., Conner, T. S., Herman, A. I., Cillessen, A. H., y Kranzler, H. R. (2007) Interactive effects on the serotonin transporter 5-HTTLPR polymorphism and stressful life events on college student drinking and drug use. Biological Psychiatry, 61, 609-616.
• Crippa, J.A., Zuardi, A.W., Martín-Santos, R., Bhattacharyya, S., Atakan, Z., McGuire, P., y Fusar-Poli, P. (2009). Cannabis ans anxiety: a critical review of the evidence. Human Psychopharmacology: Clinical and Experimental, 24, 515-523.
• Croissant, B., Grosshans, M., Klein, O., Dile, A., y Mann, K. (2005). Scheme-based benzodiazepine detoxification with oxcarbazepine -- a case report. Pharmacopsychiatry, 38, 222-223.
• Da Rocha, F. F., Bamberg, T. O., Lage, N. V., Correa, H., y Teixeira, A. L. (2009). Obsessive-compulsive disorder secondary to temporal lobe epilepsy with response to carbamazepine treatment. Progress in Neuropsychopharmacoly and Biological Psychiatry, 33, 568-569.
• Davidson, J. R., Brady, K., Mellman, T. A., Stein, M. B., y Pollack, M. H. (2007). The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. Journal of Clinical Psychopharmacology, 27, 85-88.
• Di Chiara, G., Bassareo, V., Fenu, S., De Luca, M. A., Spina, L., Cadoni, C.,… Lecca, D. (2004). Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology, 47, 227-241.
• Di Nicola, M., Martinotti, G., Tedeschi, D., Frustaci, A., Mazza, M., Sarchiapone, M.,… Janiri, L. (2010). Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome. Human Psychopharmacology, 25, 268-275.
• Díaz Mesa, E. M., García-Portilla, P., Sáiz, P. A., Bobes-Bascarán, T., Casares, M. J., Fonseca, E.,… Bobes, J. (2010). Psychometric performance of the 6th version of the Addiction Severity Index in Spanish (ASI-6). Psicothema, 22, 513-519.
• Donovan, B., Padin-Rivera, E., y Kowaliw, S. (2001). “Transcend”: initial outcomes from a posttraumatic stress disorder/substance abuse treatment program. Journal of Traumatic Stress, 14, 757-772.
• Dunlop, B. W., Papp, L., Garlow, S. J., Weiss, P. S., Knight, B. T., y Ninan, P. T. (2007). Tiagabine for social anxiety disorder. Human Psychopharmacology, 22, 241-244.
• Fatseas, M., Denis, C., Lavie, E., y Auriacombe, M. (2010). Relationship between anxiety disorders and opiate dependence—a systematic review of the literature: Implications for diagnosis and treatment. Journal of Substance Abuse Treatment, 38, 220–230.
• Federenko, I. S., Nagamine, M., Hellhammer, D. H., Wadhwa, P. D., y Wüst, S. (2004). The heritability of hypothalamus pituitary adrenal axis responses to psychosocial stress is context dependent. The Journal of Clinincal Endocrinology and Metabolism, 89, 6244-6250.
• Feinn, R., Nellissery, M., y Kranzler, H. R. (2005). Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence. American Journal of Medical Genetics, 133B, 79-84.
• Feltner, D., Wittchen, H. U., Kavoussi, R., Brock, J., Baldinetti, F., y Pande, A. C. (2008). Long-term efficacy of pregabalin in generalized anxiety disorder. International Clinical Psychopharmacology, 23, 18-28.
• Flórez, G., García-Portilla, P., Alvarez, S., Saiz, P. A., Nogueiras, L., y Bobes, J. (2008). Using topiramate or naltrexone for the treatment of alcohol-dependent patients. Alcoholism: Clinical and Experimental Research, 32, 1251-1259.
• Flórez, G., Saiz, P. A., García-Portilla, P., Alvarez, S., Nogueiras, L., y Bobes, J. (2010). Topiramate for the treatment of alcohol dependence: comparison with naltrexone. European Addiction Research, 17, 29-36.
• Furieri, F. A., y Nakamura-Palacios, E. M. (2007). Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trial. Journal of Clinical Psychiatry, 68, 1691-1700.
• Gambarana, C., Masi, F., Tagliamonte, A., Scheggi, S., Ghiglieri, O., y De Montis, M. G. (1999). A chronic stress that impairs reactivity in rats also decreases dopaminergic transmission in the nucleus accumbens: a microdialysis study. Journal of Neurochemistry, 72, 2039-2046.
• Gao, K., Sheehan, D. V., y Calabresse, J.R. (2009) Atypical antipsychotics in primary generalizad anxiety disorder or comorbid with mood disorders. Expert Review of Neurotherapeutics, 9, 1147-1158.
• García-Portilla, M. P., Bascarán, M. T., Saiz, P. A., Mateos, M., González-Quirós, M., Pérez, P.,… Bobes, J. (2005). Effectiveness of venlafaxine in the treatment of alcohol dependence with comorbid depression. Actas Españolas de Psiquiatria, 33, 41-45.
• García-Portilla, M. P., Bascarán, M. T., Sáiz, P. A., Parellada, M., Bousoño, y M., Bobes, J. (2011). Banco de instrumentos básicos para la práctica de la psquiatría clínica. 6ª ed. Majadahonda: Comunicación y Ediciones Sanitarias, S.L.
• Giner, J. (Coord). (2005). Consenso español sobre el trastorno de ansiedad generalizada. Sociedad Española de Psiquiatría y Sociedad Española de Psiquiatría Biológica. Barcelona: Ars Medica.
• Gonzalez, G., Severino, K., Sofuoglu, M., Poling, J., Olivito, A., Gonsai, K.,… Kosten, T. R. (2003. Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study. Addiction, 98, 1625-1632.
• González, G., Desai, R., Sofuoglu, M., Poling, J., Oliveto, A., Gonsai, K.,... Kosten, T. R. (2007). Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients. Drug and Alcohol Dependence, 87, 1-9.
• Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Fleischmann, R. L., Hill, C. L.,... Charney, D. S. (1989). The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Archives of General Psychiatry, 46, 1006-1011.
• Goodwin, R. D., Lipsitz, J. D., Chapman, T. F., Mannuzza, S., Klein, D. F., y Fyer, A. J. (2006). Alcohol use disorders in relatives of patients with panic disorder. Compehensive Psychiatry, 47, 88-90.
• Goossop, M. (1990). The development of a short opiate withdrawal scale (SOWS). Addictive Behaviors, 15, 487-490.
• Gorman, J., Shear, K., Cowley, D., Cross, C. D., March, J., Roth, W.,... Wang, P.S. (2006). Guía clínica para el tratamiento del trastorno de angustia. En: Asociación Americana de Psiquiatría (Ed.) Guías clínicas para el tratamiento de los trastornos psiquiátricos. Compendio. (pp 827-912). Barcelona: Ars Medica
• Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W.,... Kaplan, K. (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 61, 807-816.
• Hariri, A. R., y Weinberger, D. R. (2003). Functional neuroimaging of genetic variation in serotonergic neurotransmission. Genes, Brain, and Behavior, 2, 341-349.
• Hasin, D. S., Trautman, K. D., Miele, G. M., Samet, S., Smith, M., y Endicott, J. (1996). Psychiatric Research Interview for Substance and Mental Disorders (PRISM): Reliability for substance abusers. American Journal of Psychiatry, 153, 1195-1201
• Hasin, D. S., Stinson, F. S., Ogburn, E., y Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV Alcohol Abuse and Dependence in the United States. Archives of General Psychiatry, 64, 830-842.
• Hesse, M. (2009). Integrated psychological treatment for substance use and co-morbid anxiety or depression vs. treatment for substance use alone. A systematic review of the published literature. BMC Psychiatry, 9, 6.
• Himmerich, H., Nickel, T., Dalal, M.A., y Müller, M. B. (2007). Gabapentin treatment in a female patient with panic disorder and adverse effects under carbamazepine during benzodiazepine withdrawal. Psychiatrische Praxis, 34, 93-94.
• Hobbs, J. D. J., Kushner, M. G., Lee, S. S., Reardon, S. M., y Maurer, E. W. (2011). Meta-analysis of supplemental treatment for depressive and anxiety disorders in patients being treated for alcohol dependence. The American Journal on Addiction, 20, 319–329.
• Hollander, E., y Dell’Osso, B. (2006). Topiramate plus paroxetine in treatment-resistant obsessive-compulsive disorder. International Clinical Psychopharmacology, 21, 189-191.
• Jacobsen, L. K., Southwick, y S. M., Kosten, T. R. (2001). Substance use disorders in patients with posttraumatic stress disorder: a review of the literature. American Journal of Psychiatry, 158, 1184-1190.
• Johnson, J. G., Cohen, P., Pine, D. S., Klein, D. F., Kasen, S., y Brook, J. S. (2000). Association between cigarette smoking and anxiety disordersduring adolescence and early adulthood. JAMA, 284, 2348-2351
• Kampman, K. M., Volpicelli, J. R., McGinnis, D. E., Alterman, A. I., Weinrieb, R. M., D’Angelo, L.,... Epperson, L. E. (1998). Reliability and validity of the Cocaine Selective Severity Assessment. Addictive Behaviors, 23, 449-461.
• Kampman, K. M., Pettinati, H., Lynch, K. G., Dackis, C., Sparkman, T., Weigley, C.,... O’Brien, C. P. (2004). A pilot trial of topiramate for the treatment of cocaine dependence. Drug and Alcohol Dependence, 75, 233-240.
• Kaufman, J., Yang, B. Z., Douglas-Palumberi, H., Crouse-Artus, M., Lipschitz, D., Cristal, J. H.,... Gelenrter, J. (2007). Genetic and environmental predictors of early alcohol use. Biological Psychiatry, 61, 1228-1234.
• Kessler, R. C., Chiu, W. T., Jin, R., Ruscio, A. M., Shear, K., y Walters, E. E. (2006). The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Archives of General Psychiatry, 63, 415-424.
• Kinrys, G., Pollack, M. H., Simon, N. M., Worthington, J. J., Nardi, A. E., y Versiani, M. (2003). Valproic acid for the treatment of social anxiety disorder. International Clinical Psychopharmacology, 18, 169-172.
• Koethe, D., Juelicher, A., Nolden, B. M., Braunwarth, W. D., Klosterkötter, J., Niklewski G,... Leweke, F. (2007). Oxcarbazepine--efficacy and tolerability during treatment of alcohol withdrawal: a double-blind, randomized, placebo-controlled multicenter pilot study. Alcoholism: Clinical and Experimental Research, 31, 1188-1194.
• Koob, G., y Kreeb, M. J. (2007). Stress, dysregulation of drug reward pathways, and the transition to drug dependence. American Journal of Psychiatry, 164, 1149-1159.
• Kranzler, M. R. (1996). Evaluation and treatment of anxiety symptoms and disorders in alcoholics. Journal of Clinical Psychiatry, 57, 15-21.
• Kreeb, M. J., y Koob, G. F. (1998). Drug dependence: stress and dysregulation of brain reward pathways. Drug and Alcohol Dependence, 51, 23-47.
• Kushner, M. G., Abrams, K., y Borchardt, C. (2000). The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings. Clinical Psychology Review, 20, 149-171.
• Lanheim, A. S., Bakken, y K., Vaglum, P. (2006). Impact of comorbid psychiatric disorders on the outcome of substance abusers: a six year prospective follow-up in two Norwegian counties. BMC Psychiatry, 6, 44.
• Laucht, M., Treutlein, J., Schmid, B., Blomeyer, D., Becker, K., Buchmann, A. F.,... Banaschewski, T. (2009). Impact of psychosocial adversity on alcohol intake in young adults: moderation by the LL genotype of the serotonin transporter polymorphism. Biological Psychiatry, 66, 102-109.
• Leshner, A. I., y Koob, G. F. (1999). Drugs of abuse and the brain. Proceedings of the Association of American Physicians, 111, 99-108.
• Liebowitz, M.R. (1987). Social phobia. Modern Problems of Pharmacopsychiatry, 22, 141-173.
• Lindley, S. E., Carlson, E. B., y Hill, K. (2007). A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder. Journal of Clinical Psychopharmacology, 27, 677-681.
• Llopis Llácer, J. J., y Castillo Aguilella, A. (2008). Efficacy of oxcarbazepine treatment in patients diagnosed with cocaine abuse/dependence. Adicciones, 20, 263-270.
• Lydiard, R. B., Rickels, K., Herman, B., y Feltner, D. E. (2010). Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder. The International Journal of Neuropsychopharmacology, 13, 229-241.
• Madoz-Gúrpide, A., García Vicent, V., Luque Fuentes, E., y Ochoa Mangado, E. (2013). Variables predictivas del alta terapéutica entre pacientes con patología dual grave atendidos en una comunidad terapéutica de drogodependientes con unidad psiquiátrica. Adicciones, 25, 300-308.
• Malek-Ahmadi, P., y Hanretta, A. T. (2004). Possible reduction in posttraumatic stress disorder symptoms with oxcarbazepine in a patient with bipolar disorder. The Annals of Pharmacotherapy, 38, 1852-1854.
• Manzanares, J., García, M. S., Celorrio, M. L., Sánchez, M. M., y Rubio, G. (2010). Trastornos por ansiedad y adicciones. En: G. Haro, J. Bobes, M. Casas, J. Didia, G. Rubio (Eds.), Tratado sobre patología dual. Reintegrando la salud mental (pp. 531-571). Castellón: MRA Médica.
• Marmorstein, N. R. (2012). Anxiety disorders and substance use disorders: different associations by anxiety disorder. Journal of Anxiety Disorders, 26, 88-94.
• Marquenie, L. A., Schadé, A., van Balkom, A. J., Comijs, H. C., de Graaf, R., Vollebergh, W.,... van den Brink,, W. (2007). Origin of the comorbidity of anxiety disorders and alcohol dependence: findings of a general population study. European Addiction Research, 13, 39-49.
• Martínez-Raga, J., Sabater, A., Perez-Galvez, B., Castellano, M., y Cervera, G. (2004). Add-on gabapentin in the treatment of opiate withdrawal. Progress in Neuropsychopharmacology and Biological Psychiatry, 28, 599-601.
• Martinotti, G., Romanelli, R., Di Nicola, M., Reina, D., Mazza, M., y Janiri, L. (2007). Oxcarbazepine at high dosages for the treatment of alcohol dependence. The American Journal on Addictions, 16, 247-248.
• Martinotti, G., Di Nicola, M., Tedeschi, D., Andreoli, S., Reina, D., Pomponi, M.,... Janiri, L. (2010a). Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial. Journal of Psychopharmacology, 24, 1367-1374.
• Martinotti, G., di Nicola, M., Frustaci, A., Romanelli, R., Tedeschi, D., Guglielmo, R.,... Janiri, L. (2010b). Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial. Addiction, 105, 288-299.
• Mateo, Y., Lack, C. M., Morgan, D., Roberts, D. C., y Jones, S. R. (2005). Reduced dopamine terminal function and insensitivity to cocaine following cocaine binge self-administration and deprivation. Neuropsychopharmacology, 30, 1455-1463.
• McKeehan, M. B., y Martin, D. (2002). Assessment and treatment of anxiety disorders and comorbid alcohol/ other drug dependency. Alcoholism Treatment Quarterly, 20, 45–59.
• Merikangas, K. R., Mehta, R. L., Molnar, B. E., Walters, E. E., Swendsen, J. D., Aguilar-Gaziola, S.,... Kessler, R. C. (1998). Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. Addictive Behaviors, 23, 893-907.
• Ministerio de Sanidad y Consumo. (2008) Guía de Práctica Clínica para el Manejo de Pacientes con Trastornos de Ansiedad en Atención Primaria. Agencia Laín Entralgo. Unidad de Evaluación de Tecnologías Sanitarias. Madrid
• Montgomery, S. A., Herman, B. K., Schweizer, E., y Mandel, F. S. (2009). The efficacy of pregabalin and benzodiazepines in generalized anxiety disorder presenting with high levels of insomnia. International Clinical Psychopharmacology, 24, 214-222.
• NICE. (2011) Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults. Management in primary, secondary and community care. National Clinical Guideline Number 113.
• Nicolini, H., Herrera, K., Páez, F., Sánchez de Carmona, M., Orozco, B., Lodeiro, G.,... de la Fuenta, J.R. (1996). Traducción al español y confiabilidad de la Escala Yale-Brown para el trastorno obsesivo-compulsivo. Salud Mental, 5, 13-16.
• North, C. S., Tivis, L., McMillen, J. C., Pfefferbaum, B., Spitznagel, E. L., Cox, J.,… Smith, E. M. (2002). Psychiatric disorders in rescue workers after the Oklahoma City bombing. American Journal of Psychiatry, 159, 857-859.
• Nunes, E. V., McGrath, P. J., y Quitkin, F. M. (1995). Treating anxiety in patients with alcoholism. Journal of Clinical Psychiatry, 57, 3-9.
• Ochoa, E., Salvador, E., Vicente, M., y Madoz, A. (2010). Comorbilidad psiquiátrica y adicciones. En: Pereiro Gómez, C. (Ed.), Manual de adicciones para médicos especialistas en formación (pp. 701-731). Madrid: DGPNSD
• OECD (2012), OECD Health Data: Pharmaceutical market, OECD Health Statistics (database). doi: 10.1787/data-00545-en (Recuperado el 30 de Enero de 2013)
• Oslin, D. W., Berrettini, W., Kranzler, H. R., Pettinati, H., Gelernter, J., Volpicelli, J. R.,… O’Brien, C.P. (2003). A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology, 28, 1546-1552.
• Oulis, P., Florakis, A., Tzanoulinos, G., y Papadimitriou, G. N. (2008a). Pregabalin in the treatment of benzodiazepine-induced obsessive-compulsive disorder. Progress in Neuropsychopharmacology and Biological Psychiatry, 32, 2000-2001.
• Oulis, P., Masdrakis, V. G., Karapoulios, E., Karakatsanis, N. A., Kouzoupis, A. V., Konstantakopoulos, G.,... Soldatos, C. R. (2008b) Pregabalin augmentation to sertraline-risperidone combination in the treatment of obsessive-compulsive disorder. Primary Care Companion to the Journal of Clinical Psychiatry, 10, 249.
• Oulis, P., Masdrakis, V. G., Karapoulios, E., Karakatsanis, N. A., Kouzoupis, A. V., Konstantakopoulos, G.,... Soldatos, C. R. (2009). Tiagabine augmentation to fluvoxamine-risperidone combination in the treatment of obsessive-compulsive disorder. The World Journal of Biological Psychiatry, 10, 953-955.
• Pacak, K., Tjurmina, O., Palkovits, M., Goldstein, D. S., Koch, C. A., Hoff, T.,... Chrousos, G.P. (2002). Chronic hypercortisolemia inhibits dopamine synthesis and turnover in the nucleus accumbens: an in vivo microdialysis study. Neuroendocrinology, 76, 148-157.
• Pae, C. U., Marks, D. M., Han, C., Masand, P. S., y Patkar, A. A. (2009). Pregabalin augmentation of antidepressants in patients with accident-related posttraumatic stress disorder: an open label pilot study. International Clinical Psychopharmacology, 24, 29-33.
• Pande, A. C., Davidson, J. R., Jefferson, J. W., Janney, C. A., Katzelnick, D. J., Weisler, R. H.,... Sutherland, S. M. (1999). Treatment of social phobia with gabapentin: a placebo-controlled study. Journal of Clinical Psychopharmacology, 19, 341-348.
• Pande, A. C., Pollack, M. H., Crockatt, J., Greiner, M., Chouinard, G., Lydiard, R. B.,... Shiovitz, T. (2000). Placebo-controlled study of gabapentin treatment of panic disorder. Journal of Clinical Psychopharmacology, 20, 467-471.
• Pande, A. C., Feltner, D. E., Jefferson, J. W., Davidson, J. R., Pollack, M., Stein, M. B.,... Werth, J. L. (2004). Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study. Journal of Clinical Psychopharmacology, 24, 141-149.
• Paparrigopoulos, T., Tzavellas, E., Karaiskos, D., Malitas, P., y Liappas, I. (2009). An open pilot study of tiagabine in alcohol dependence: tolerability and clinical effects. Journal of Psychopharmacology, 24, 1375-1380
• Pasche, S. (2012). Exploring the Comorbisity of Anxiety and Substance Use Disorders. Current Psychiatry Reports, 14, 176–181
• Patterson, W. M., Dohn, H. H., Bird, J., y Patterson, G. A. (1983). Evaluation of suicidal patients: the SAD PERSONS scale. Psychosomatics, 24, 343-345, 348-349.
• Pettinati, H. M., Volpicelli, J. R., Kranzler, H. R., Luck, G., Rukstalis, M. R., y Cnaan, A. (2000). Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype. Alcoholism: Clinical and Experimental Research, 24, 1041-1049.
• Pezawas, L., Meyer-Lindenberg, A., Drabant, E. M., Verchinski, B. A., Munoz, K. E., Kolachana, B. S.,… Weinberger, D. R. (2005). 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nature Neuroscience, 8, 828-834.
• Piazza, P. V., Deminiere, J. M., le Moal, M., y Simon, H. (1990). Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Research, 514, 22-26.
• Piazza, P. V., Maccari, S., Deminière, J. M., Le Moal, M., Mormède, P., y Simon, H. (1991). Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proceedings of the National Academy of Sciences of the United States of America, 88, 2088-2092.
• Pollack, M. H., Tiller, J., Xie, F., y Trivedi, M. H. (2008). Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies. Journal of Clinical Psychopharmacology, 28, 308-316.
• Posner, K., Brown, G. K., Stanley, B., Brent, D. A., Yershova, K. V., Oquendo, M. A.,… Mann, J. J. (2011). The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults. The American Journal of Psychiatry, 168, 1266-1277
• Posternak, M. A., y Mueller, T. I. (2001). Assessing the risks and benefits of benzodiazepines for anxiety disorders in patients with a history of substance abuse or dependence. The American Journal on Addictions, 10, 48-68.
• Radel, M., Vallejo, R. L., Iwata, N., Aragon, R., Long, J. C., Virkkunen, M.,... Goldman, D. (2005). Haplotype-based localization of an alcohol dependence gene to the 5q34 {gamma}-aminobutyric acid type A gene cluster. Archives of General Psychiatry, 62, 47-55.
• Randall, C., Thomas, S., y Thevos, A. (2001). Concurrent alcoholism and social anxiety disorder: a first step toward developing effective treatments. Alcoholism: Clinical and Experimental Research, 25, 210–220.
• Reis, A. D., Castro, L. A., Faria, R., y Laranjeira, R. (2008). Craving decrease with topiramate in outpatient treatment for cocaine dependence: an open label trial. Revista Brasileira de Psiquiatria, 30, 132-135.
• Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L.,... Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA). JAMA, 264, 2511-2518.
• Rosen, M. I., Pearsall, H. R., y Kosten, T. R. (1998). The effect of lamotrigine on naloxone-precipitated opiate withdrawal. Drug and Alcohol Dependence, 52, 173-176.
• Rubio, G., Bermejo, J., Caballero, M. C., y Santo-Domingo, J. (1998). Validación de la prueba para la identificación de trastornos por uso de alcohol (AUDIT) en atención primaria. Revista Clinica Española, 198, 11-14.
• Rubio, G., López-Muñoz, F., y Álamo, C. (2002). Tratamiento farmacológico de los trastornos de ansiedad en dependientes de sustancias. En: G. Rubio, F. López-Muñoz, C. Álamo, J. Santo-Domingo (Eds.), Trastornos psiquiátricos y abuso de sustancias (pp. 315-329) Madrid: Editorial Médica Panamericana
• Rubio, G., López-Muñoz, y F., Alamo, C. (2006). Effects of lamotrigine in patients with bipolar disorder and alcohol dependence. Bipolar Disorders, 8, 289-293.
• Rubio, G., Martínez-Gras, I., y Manzanares, J. (2009). Modulation of impulsivity by topiramate: implications for the treatment of alcohol dependence. Journal of Clinical Psychopharmacology, 29, 584-589.
• Sáiz, P. A., García-Portilla, M. P., y Bobes, J. (2011). Instrumentos de evaluación. En: J. Bobes, J. Giner, J. Sáiz (Coord.), Suicidio y psiquiatría: Recomendaciones preventivas y manejo del comportamiento suicida (pp. 95-122) Madrid: Editorial Triacastela
• San Molina, L. (Coord.) (2004). Consenso sobre patología dual. Sociedad Española de Psiquiatría y Sociedad Española de Psiquiatría Biológica. Barcelona: Ars Medica.
• San Molina, L., Casas, M., Arranz, B., Bruguera, E., Busquets, E., Camps, N.,... Valls Lapica, J. J. (2005). Patología dual. En: P. A. Soler, J. Gascón (Coord.), Recomendaciones terapéuticas en los trastornos mentales RTM-III (pp. 63-82) Barcelona: Ars Medica
• Sareen, J., Chartier, M., Paulus, M. P., y Stein, M. B. (2006). Illicit drug use and anxiety disorders: findings from two community surveys. Psychiatry Research, 142, 11-17.
• Sattar, S. P., Schultz, S. K., Arndt, S., Soundy, T., y Petty, F. (2007). Long-term adjunctive quetiapine may reduce substance use--a preliminary retrospective study. South Dakota Medicine, 60, 437-443.
• Saunders, J. B., Aasland, O. G., Babor, T. F., de la Fuente, J. R., y Grant, M. (1993). Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction, 88, 791-804.
• Schadé, A., Marquenie, L. A., van Balkom, A. J., Koeter, M. W., de Beurs, E., van den Brink, W.,… van Dyck, R. (2005). The effectiveness of anxiety treatment on alcohol-dependent patients with a comorbid phobic disorder: a randomized controlled trial. Alcoholism: Clinical and Experimental Research, 29, 794-800.
• Schäfer, I., y Najavits, L. M. (2007). Clinical challenges in the treatment of patients with posttraumatic stress disorder and substance abuse. Curr Opin Psychiatry, 20, 614-618.
• Schneier, F. R., Foose, T. E., Hasin, D. S., Heimberg, R. G., Liu, S. M., Grant, B. F.,… Blanco, C. (2010). Social anxiety disorder and alcohol use disorder co-morbidity in the National Epidemiologic Survey on Alcohol and Related Conditions. Psychological Medicine, 40, 977-988.
• Schultz, W., Dayan, P., y Montague, P. R. (1997). A neural substrate of prediction and reward. Science, 275, 1593-1599.
• Secades, R., Rodriguez-García, E., Valderrey, J., Fernández-Hermida, J., Vallejo, G., y Jiménez-García, J. (2003). El consumo de psicofármacos en pacientes que acuden a Atención Primaria en el Principado de Asturias (España). Psicothema, 15, 650-655.
• Sheehan, D. V., Lecrubier, Y., Harnett-Sheehan, K., Janavs, J., Weiller, E., Kreskiner, A.,… Dunbar, G. (1997). Reliability and validity of the MINI Internacional Neuropsychiatric Interview (MINI): according to the SCID-P and its reliability. European Psychiatry, 12, 232-41.
• Sheehan, D. V., Sheehan, K. H., Raj, B. A., y Janavs, J. (2007). An open-label study of tiagabine in panic disorder. Psychopharmacology Bulletin, 40, 32-40.
• Sociedad Española de Patología Dual. (2009). Estudio epidemiológico sobre la prevalencia de patología dual en la Comunidad de Madrid. Recuperado de http://www.patologiadual.es /docs /estudio_epidemiologico_PD_CE2008_NOV08.pdf
• Spila, B., Szumiłło, A. (2006). Gabapentin (GBP) in panic disorders--case report. Psychiatria Polska, 40, 1061-1068.
• Stein, M. B., Kerridge, C., Dimsdale, J. E., y Hoyt, D. B. (2007). Pharmacotherapy to prevent PTSD: Results from a randomized controlled proof-of-concept trial in physically injured patients. Journal of Traumatic Stress, 20, 923-932.
• Stein, D. J., Baldwin, D. S., Baldinetti, F., y Mandel, F. (2008). Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: a pooled analysis of 6 studies. European Neuropsychopharmacology, 18, 422-430.
• Stein, D. J., Bruce Lydiard, R., Herman, B. K., y Mandel, F. S. (2009). Impact of gastrointestinal symptoms on response to pregabalin in generalized anxiety disorder: results of a six-study combined analysis. International Clinical Psychopharmacology, 24, 126-132.
• Sullivan, J. T., Sykora, K., Schneiderman, J., Naranjo, C. A., y Sellers, E. M. (1989). Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). British Journal of Addiction, 84, 1353-1357.
• Tejero, A., Trujols, J., y Siñol, N. (2003a). Evaluación del craving de cocaína. En: A. Tejero, J. Trujols (Eds.), Instrumentos clínicos para la evaluación de la dependencia de cocaína (pp. 23-50). Barcelona: Ars Medica.
• Tejero, A., Trujols, J., y Gil, L. (2003b). Evaluación del síndrome de abstinencia de cocaína. En: A. Tejero, J. Trujols (Eds.), Instrumentos clínicos para la evaluación de la dependencia de cocaína (pp13-22). Barcelona: Ars Medica.
• Terra, M. B., Barros, H. M. T., Stein, A. T., Figueira, I., Jorge, M. R., Palermo, L. H.,… Da Silveira, D. X. (2006). Social anxiety disorder in 300 patients hospitalizad for alcoholism in Brazil: high prevalence and undertreatment. Compehensive Psychiatry, 47, 463-467.
• Thomas, S. E., Randall, P. K., Book, S. W., y Randall, C. L. (2008). A complex relationship between co-ocurring social anxiety and alcohol use disorders: what effect does treating anxiety have on drinking? Alcoholism: Clinical and Experimental Research, 32, 77-84
• Tiet, Q. Q., y Mausbach, B. (2007). Treatments for patients with dual diagnosis: a review. Alcoholism: Clinical and Experimental Research, 31, 513-536.
• Tiffany, S. T., Singleton, E., Haertzen, C. A., y Henningfield, J.E. (1993). The development of a cocaine craving questionnaire. Drug and Alcohol Dependence, 34, 19-28.
• Torrens, M., Serrano, D., Astals, M., Pérez-Domínguez, G., y Martín-Santos, R. (2004). Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV. American Journal of Psychiatry, 161, 1231-1237.
• Tucker, P., Trautman, R. P., Wyatt, D. B., Thompson, J., Wu, S. C., Capece, J. A.,… Rosenthal, N. R. (2007). Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study. Journal of Clinical Psychiatry, 68, 201-206.
• Tyrer, P., Murphy, S., y Riley, P. (1990). The benzodiazepine withdrawal symptom questionnaire. Journal of Affective Disorders, 19, 53-61.
• Uhart, M., McCaul, M. E., Oswald, L. M., Choi, L., y Wand, G. S. (2004). GABRA6 gene polymorphism and an attenuated stress response. Molecular Psychiatry, 9, 998-1006.
• Uhart, M., y Wand, G. S. (2009). Stress, alcohol and drug interaction: an update of human research. Addiction Biology, 14, 43-64.
• Ursano, R. J., Bell, C., Eth, S., Friedman, M., Norwood, A., Pfefferbaum, B.,... Benedek, D. M. (2006). Guía clínica para el tratamiento de los trastornos por estrés agudo y estrés postraumático. En: Guías clínicas para el tratamiento de los trastornos psiquiátricos. Compendio 2006. Asociación Americana de Psiquiatría (pp. 1133-1266). Barcelona: Ars Medica.
• Uzun, O. (2010). Lamotrigine as an augmentation agent in treatment-resistant obsessive-compulsive disorder: a case report. Journal of Psychopharmacology, 24, 425-427.
• Van Ameringen, M., Manzini, C., Pipe, B., Oakman, J., y Bennett, M. (2004). An open trial of topiramate in the treatment of generalized social phobia. Journal of Clinical Psychiatry, 65, 1674-1678.
• Van Ameringen, M., Mancini, C., Patterson, B., y Bennett, M. (2006). Topiramate augmentation in treatment-resistant obsessive-compulsive disorder: a retrospective, open-label case series. Depression and Anxiety, 23, 1-5.
• Van Laar, M., van Dorsselaer, S., Monshouwer, K., y de Graaf, R. (2007). Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population? Addiction, 102, 1251-1260.
• Verduin, M. L., McKay, S., y Brady, K. T. (2007). Gabapentin in comorbid anxiety and substance use. The American Journal on Addictions, 16, 142-143.
• Volkow, N. D., Fowler, J. S., y Wang, G. J. (2003). Positron emisión tomography and single-photon emision computed tomography in substance abuse research. Seminars in Nuclear Medicine, 33, 114-128.
• Wand, G. S., Oswald, L. M., McCaul, M. E., Wong, D. F., Johnson, E., Zhou, Y.,... Kumar, A. (2007). Association of amphetamine-induced striatal dopamine release and cortisol responses to psychological stress. Neuropsychopharmacology, 32, 2310-2320.
• Watkins, K. E., Hunter, S. B., Burnam, M. A., Pincus, H. A., y Nicholson, G. (2005). Review of treatment recommendations for persons with a co-occurring affective or anxiety and substance use disorder. Psychiatric Services, 56, 913-926.
• Weiss, F., Parsons, L. H., Schulteis, G., Hyytiä, P., Lorang, M. T., Bloom, F. E.,... Koob, G. F. (1996). Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats. The Journal of Neuroscience, 16, 3474-3485.
• Winhusen, T. M., Somoza, E. C., Harrer, J. M., Mezinskis, J. P., Montgomery, M. A., Goldsmith, R. J.,... Elkashef, A. (2005). A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments. Addiction, 100, 68-77.
• Winhusen, T., Somoza, E., Ciraulo, D. A., Harrer, J. M., Goldsmith, R. J., Grabowski, J.,... Elkashef, A. (2007). A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence. Drug and Alcohol Dependence, 91, 141-148.
• Wüst, S., Van Rossum, E. F., Federenko, I. S., Koper, J. W., Kumsta, R., y Hellhammer, D. H. (2004). Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress. The Journal of Clinical Endocrinology & Metabolism, 89, 565-573.
• Zullino, D. F., Cottier, A. C., y Besson, J. (2002) Topiramate in opiate withdrawal. Progress in Neuropsychopharmacology and Biological Psychiatry, 26, 1221-1223.
• Zvolensky, M. J., Bernstein, A., Sachs-Ericsson, N., Schmidt, N. B., Buckner, J. D., y Bonn-Miller, M. O. (2006). Lifetime associations between cannabis, use, abuse, and dependence and panic attacks in a representative sample. Journal of Psychiatry Research, 40, 477-486.
• Zwanzger, P., Eser, D., Nothdurfter, C., Baghai, T. C., Möller, H. J., Padberg, F., y Rupprecht, R. (2009). Effects of the GABA-reuptake inhibitor tiagabine on panic and anxiety in patients with panic disorder. Pharmacopsychiatry, 42, 266-269.